Chronic diseases represent a huge proportion of human illness. They include cardiovascular disease, cancer, chronic respiratory diseases and diabetes.
The main objectives of this Research Seminar are to discuss the:
- burden of complex chronic co-morbidities and
- relationship between markers of organ and systemic inflammation
The main educational aims are to:
- define the most important and frequent co-morbidities in elderly patients, particularly those with COPD
- provide updated information on the most common chronic disease, ie coronary and/or peripheral arterial diseases, systemic arterial hypertension, osteoporosis, metabolic syndrome, chronic heart failure, chronic obstructive pulmonary disease
- emphasise the limitations of single disease-oriented clinical practice guidelines, and the need for a more comprehensive "internistic" approach to patients with multiple chronic co-morbidities
- suggest that chronic inflammation might represent the common pathogenetic link between the different chronic diseases present in the elderly
Overview of smoking-related disease D. Mannino (Lexington, Ky, United States of America)
| |
Systemic effects of smoking W. MacNee (Edinburgh, United Kingdom)
| |
COPD coronary/peripheral vascular disease G. Mancini (Vancouver, British Columbia, Canada)
| |
COPD and CHF F. Rutten (Utrecht, Netherlands)
| |
COPD and cancer S. Spiro (London, United Kingdom)
| |
Sleep disorders in COPD and complex chronic comorbidities W. McNicholas (Dublin, Ireland)
| |
The role of inflammation in diabetes and obesity M. Porta (Torino, Italy)
| |
The role of inflammation in myocardial infarction F. Crea (Roma, Italy)
| |
The role of inflammation in chronic heart failure P. Poole-Wilson (London, United Kingdom)
| |
The role of inflammation in cachexia P. Wagner (La Jolla, Ca, United States of America)
| |
The role of inflammation in COPD R. Djukanovic (Southampton, United Kingdom)
| |
Osteoporosis and inflammation N. Hamdy (Leiden, Netherlands)
| |
Hypertension and inflammation E. Schiffrin (Montreal, Canada)
| |
Chronic inflammatory gastrointestinal diseases F. Pallone (Rome, Italy)
| |
Mechanisms of exacerbation of respiratory symptoms in patients with metabolic syndrome B. Muller (Basel, Switzerland)
| |
Treatment strategies for patients with complex chronic comorbidities J. Drazen (Boston, Ma, United States of America)
| |
Role of anti-inflammatory treatments in complex chronic comorbidities C. Page (London, United Kingdom)
| |
Development of new treatments for complex chronic comorbidities P. J. Barnes (London, United Kingdom)
| |
Mechanisms of exacerbation of respiratory symptoms in patients with COPD A. Anzueto (San Antonio, United States of America)
| |
Mechanisms of exacerbation of respiratory symptoms in patients with CHF P. M. A. Calverley (Liverpool, United Kingdom)
| |